Dion Warren is Vice President, Head of US Oncology Business Unit (US OBU) at Takeda. He joined the company in May 2002 (but in December 2001 as contractor) and leads Takeda Oncology’s efforts in the US to accelerate capabilities, culture and commercialization of medicines.
During his more than 18 years at Takeda, Mr. Warren has held a number of diverse roles with increasing responsibility and was a key leader in the acquisition of Millennium Pharmaceuticals. Prior to becoming Head of US OBU, Mr. Warren was Head of Europe and Canada OBU, successfully globalizing Takeda Oncology. While in Emerging Markets, Mr. Warren built the oncology team and business across approximately 50 countries and helped develop Takeda’s industry-leading Access to Medicines program.
Mr. Warren holds Bachelor of Science degrees in Finance and Real Estate from Florida State University.